| Detailed information |
|---|
| CancerLivER ID | 2549 |
| Biomarker | Stathmin 1 |
| Biomarker Name/Symbol (given in Publication) | Stathmin 1 |
| Biomolecule | Protein |
| Subject | Human |
| Degree of Validity | Potential diagnostic marker for HBV-associated HCC; but not validated on independent dataset |
| Experimental Condition | HCC v/s non-tumor |
| Cancer type | Hepatocellular carcinoma |
| Regulation | Upregulated in HCC than non-HCC (avg ratio HCC to non-tumor 11.1 +/- 15.7) |
| Level of significance | p < 0.05 |
| Source | Tissue |
| PMID | 15759316 |
| Type of Biomarker | Diagnostic |
| Pathway | Cell proliferation |
| Cohort | Paired HCC and non-tumorous from 10 HCC patients |
| Sensitivity | NA |
| Specificity | NA |
| Accuracy | NA |
| AUC | NA |
| Disease | HBV-associated HCC |
| Year of Publication | 2005 |
| Clinical trial | YES |
| NCT No# (Clinical trial) | NCT01251458 |